These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33962128)

  • 1. Subtypes of depression characterized by different cognitive decline and brain activity alterations.
    Yang X; Qi S; Wang M; Calhoun VD; Sui J; Li T; Ma X
    J Psychiatr Res; 2021 Jun; 138():413-419. PubMed ID: 33962128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers.
    Watson AJ; Giordano A; Suckling J; Barnes TRE; Husain N; Jones PB; Krynicki CR; Lawrie SM; Lewis S; Nikkheslat N; Pariante CM; Upthegrove R; Deakin B; Dazzan P; Joyce EM
    Psychol Med; 2023 May; 53(7):2842-2851. PubMed ID: 35177144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications.
    Pu S; Noda T; Setoyama S; Nakagome K
    Psychol Med; 2018 Dec; 48(16):2717-2729. PubMed ID: 29679991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive Decline.
    Weinberg D; Lenroot R; Jacomb I; Allen K; Bruggemann J; Wells R; Balzan R; Liu D; Galletly C; Catts SV; Weickert CS; Weickert TW
    JAMA Psychiatry; 2016 Dec; 73(12):1251-1259. PubMed ID: 27829096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia.
    Ohi K; Takai K; Sugiyama S; Kitagawa H; Kataoka Y; Soda M; Kitaichi K; Kawasaki Y; Ito M; Shioiri T
    CNS Spectr; 2021 Mar; ():1-7. PubMed ID: 33731244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance on the Wechsler Adult Intelligence Scale (WAIS) in Japanese patients with bipolar and major depressive disorders in euthymic and depressed states.
    Matsuo J; Hori H; Ishida I; Hiraishi M; Ota M; Hidese S; Yomogida Y; Kunugi H
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):128-137. PubMed ID: 33368739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive profile of outpatients with unipolar depressive disorders.
    Schwert C; Stohrer M; Aschenbrenner S; Weisbrod M; Schröder A
    J Clin Exp Neuropsychol; 2019 Nov; 41(9):913-924. PubMed ID: 31437083
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY; Ho NF; Sum MY; Collinson SL; Sim K
    Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysis.
    Guo W; Liu B; Wei X; Ju Y; Wang M; Dong Q; Lu X; Sun J; Zhang L; Guo H; Zhao F; Li W; Li Z; Liao M; Zhang L; Liu J; Zhang Y; Li L
    Psychiatry Res; 2023 Sep; 327():115413. PubMed ID: 37579539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis.
    MacKenzie LE; Uher R; Pavlova B
    JAMA Psychiatry; 2019 Mar; 76(3):297-305. PubMed ID: 30586133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Intellectual Functioning and Cognitive Performance to Brain Structure in Schizophrenia.
    Czepielewski LS; Wang L; Gama CS; Barch DM
    Schizophr Bull; 2017 Mar; 43(2):355-364. PubMed ID: 27369471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligence decline between present and premorbid IQ in schizophrenia: Schizophrenia Non-Affected Relative Project (SNARP).
    Ohi K; Shimada T; Kataoka Y; Koide Y; Yasuyama T; Uehara T; Okubo H; Kawasaki Y
    Eur Neuropsychopharmacol; 2019 May; 29(5):653-661. PubMed ID: 30885440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain network functional connectivity and cognitive performance in major depressive disorder.
    Albert KM; Potter GG; Boyd BD; Kang H; Taylor WD
    J Psychiatr Res; 2019 Mar; 110():51-56. PubMed ID: 30594024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connectivity patterns of cognitive control network in first episode medication-naive depression and remitted depression.
    Jiao K; Xu H; Teng C; Song X; Xiao C; Fox PT; Zhang N; Wang C; Zhong Y
    Behav Brain Res; 2020 Feb; 379():112381. PubMed ID: 31770543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood cognition and lifetime risk of major depressive disorder in extremely low birth weight and normal birth weight adults.
    Dobson KG; Schmidt LA; Saigal S; Boyle MH; Van Lieshout RJ
    J Dev Orig Health Dis; 2016 Dec; 7(6):574-580. PubMed ID: 27453448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory and processing speed impairments in first-episode drug-naïve patients with major depressive disorder.
    Hu Y; Li J; Zhao Y; Dong Z; Qiu P; Yang S; Xu H; Kuang W; Gong Q
    J Affect Disord; 2023 Feb; 322():99-107. PubMed ID: 36368425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.
    Liang S; Deng W; Li X; Greenshaw AJ; Wang Q; Li M; Ma X; Bai TJ; Bo QJ; Cao J; Chen GM; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Si TM; Wang CY; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yu H; Yao JS; Yao SQ; Yin YY; Yuan YG; Zang YF; Zhang AX; Zhang H; Zhang KR; Zhang ZJ; Zhao JP; Zhou RB; Zhou YT; Zou CJ; Zuo XN; Yan CG; Li T
    Neuroimage Clin; 2020; 28():102514. PubMed ID: 33396001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cognitive impairment in treatment-resistant depression.
    Gregory E; Torres IJ; Ge R; Blumberger DM; Downar JH; Daskalakis ZJ; Lam RW; Vila-Rodriguez F
    J Affect Disord; 2020 Sep; 274():593-601. PubMed ID: 32663992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.